Abera Bioscience AB (FRA:8WK)
Germany · Delayed Price · Currency is EUR 0.5400
-0.0300 (-5.26%)
At close: Nov 28, 2025
Abera Bioscience AB Market Cap
Abera Bioscience AB has a market cap or net worth of €11.01 million as of December 1, 2025. Its market cap has increased by 123.47% in one year.
Market Cap
11.01M
Enterprise Value
8.90M
Revenue
1.56M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.54
Market Cap Chart
Since February 24, 2021, Abera Bioscience AB's market cap has decreased from 11.47M to 11.01M, a decrease of -4.03%. That is a compound annual growth rate of -0.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 1, 2025 | 11.01M | 82.18% |
| Dec 30, 2024 | 6.04M | -9.75% |
| Dec 29, 2023 | 6.69M | 20.37% |
| Dec 30, 2022 | 5.56M | -67.10% |
| Dec 30, 2021 | 16.90M | 47.38% |
| Feb 24, 2021 | 11.47M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.88B |
| Siemens Aktiengesellschaft | 176.79B |
| Allianz SE | 141.56B |
| Deutsche Telekom AG | 132.19B |
| Siemens Energy AG | 98.23B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.85B |
| Rheinmetall AG | 67.93B |
| Deutsche Bank Aktiengesellschaft | 58.37B |